Author: Quark

QuarkBio at BioTaiwan 2018

It's that time of the year again! BioTaiwan 2018 will be held from 7/19-22 at Nangang Exhibition Hall. This year, QuarkBio is located on the 4th floor at Booth M308. Come visit our booth to participate in a variety of events, including: A chance for

A Novel Multi-Gene Detection Platform for the Analysis of miRNA Expression

QuarkBio’s newest publication demonstrates the use of QuarkBio’s PanelChip™ Analysis System as a powerful technology for discovering and validating extracellular miRNA cancer biomarkers. By analyzing miRNA levels in the plasma, we were able to discover miRNA expression patterns capable of separating healthy subjects from patients with oral

Dr. Chen-Yu Zhang of Nanjing University visits QuarkBio to share his expansive microRNA-based research

QuarkBio at the 12th International Conference on Genomics (ICG-12)

This year, Dr. Eric P. Yang, vice president of QuarkBio, will be introducing QuarkBio's proprietary PanelChip™ Analysis Platform during ICG-12's Product Launch section (10/27 from 1:30 to 3:30 pm). If you can't make it to Product Launch, be sure to come by our booth located on

Co-development of tumor microenvironment panel with ACT Genomics to assist in predicting immunotherapy response in cancer patients

Immunotherapy has welcomed a new era of cancer treatment. By utilizing the patient's own body's natural defenses to fight cancer, the patients that respond to immunotherapy have great prognoses. However, not every cancer patient responds well to immunotherapy. There are three indications that are currently

New Collaboration With Min-Sheng General Hospital

QuarkBio has partnered with Min-Sheng General Hospital, one of the top hospitals in Taiwan, to implement an early stage cancer detection tool for multiple types of cancer. Min-Sheng General Hospital will be providing 1,000 clinical samples as a trial run before providing the detection test as